Maria P Limberis

Title: Maria P Limberis: Innovator in Influenza Vaccine Development

Introduction

Maria P Limberis is a prominent inventor based in Philadelphia, PA, known for her significant contributions to the field of virology and vaccine development. With a total of two patents to her name, she has made strides in creating innovative solutions for combating influenza.

Latest Patents

Her latest patents include "AAV-mediated expression of anti-influenza antibodies and methods of use thereof," which provides AAV vectors expressing anti-influenza antibodies. This patent describes pharmaceutical compositions useful for delivering these antibodies for prophylactic or anti-viral purposes. Additionally, she holds a patent for "AAV mediated influenza vaccines," which involves a non-replicating recombinant adeno-associated virus (rAAV) that packages a vector genome containing nucleic acid sequences encoding four different immunoglobulin regions. These immunoglobulins are designed to provide passive immunization against influenza A and B, along with methods for vaccinating patients against the virus.

Career Highlights

Maria has worked with esteemed organizations such as the University of Pennsylvania and Janssen Biotech, Inc. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues, including Anna P Tretiakova and James M Wilson. These partnerships have further enhanced her research and development efforts in the area of influenza vaccines.

Conclusion

Maria P Limberis stands out as an influential inventor in the realm of vaccine development, particularly for influenza. Her innovative patents and collaborations reflect her commitment to advancing public health through scientific research.